Bekum America Corp v. Scantibodies Laboratory Inc

CourtMichigan Court of Appeals
DecidedOctober 20, 2025
Docket369952
StatusUnpublished

This text of Bekum America Corp v. Scantibodies Laboratory Inc (Bekum America Corp v. Scantibodies Laboratory Inc) is published on Counsel Stack Legal Research, covering Michigan Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bekum America Corp v. Scantibodies Laboratory Inc, (Mich. Ct. App. 2025).

Opinion

If this opinion indicates that it is “FOR PUBLICATION,” it is subject to revision until final publication in the Michigan Appeals Reports.

STATE OF MICHIGAN

COURT OF APPEALS

BEKUM AMERICA CORP, UNPUBLISHED October 20, 2025 Plaintiff/Counterdefendant-Appellee, 9:56 AM

v No. 369952 Ingham Circuit Court SCANTIBODIES LABORATORY, INC., LC No. 21-000382-CB

Defendant/Counterplaintiff-Appellant.

Before: GARRETT, P.J., and RICK and FEENEY, JJ.

PER CURIAM.

In this breach-of-contract action, defendant/counterplaintiff-appellant, Scantibodies Laboratory, Inc., appeals as of right the circuit court’s consent judgment granting a final money judgment of $500,000 in favor of plaintiff/counterdefendant-appellee, Bekum America Corp, and against Scantibodies. But, Scantibodies is actually challenging the earlier trial court orders granting: (1) summary disposition in Bekum’s favor with respect to Scantibodies’ counter- complaint, and (2) partial summary disposition in Bekum’s favor with respect to Count 1 of Bekum’s complaint.

On appeal, Scantibodies argues that the trial court erred by finding that Bekum: (1) did not breach the H-121S contract, (2) did not breach its express warranty, (3) did not breach the 707D contracts, (4) was not liable for fraudulent or innocent misrepresentation, and (5) was entitled to its actual attorney fees and costs. We conclude that the trial court erred by ruling as a matter of law that Bekum did not breach the H-121S contract, or its express warranty because a factual dispute remains. But we affirm the trial court’s findings that: Scantibodies anticipatorily breached the 707D contracts, Scantibodies could not establish its misrepresentation claims, and Bekum was entitled to recover its actual attorney fees. Accordingly, we: (1) vacate, in part, the trial court’s order granting Bekum’s motion for summary disposition of Scantibodies’ counter complaint; (2) affirm the trial court’s order granting Bekum’s partial motion for summary disposition; (3) vacate the trial court’s consent judgment; and (4) remand for further proceedings regarding Scantibodies’ H-121S breach-of-contract claim, Scantibodies’ H-121S breach-of-warranty claim, and reevaluation of damages.

-1- I. FACTS

This case arises out of four separate contracts memorializing Scantibodies’ purchase of one “H-121S machine” and three “707D machines” from Bekum.

A. SCANTIBODIES BUSINESS WITH QUIDEL

Before this case came about, Scantibodies prepared medical test kits for Quidel Corporation, but it did not create the pipettes packaged within the kits. In February 2020, Scantibodies reached out to Quidel, offering to invest in machinery that would allow it to become Quidel’s “2nd supplier” for its pipette needs. Scantibodies then sent sample pipettes to Xpress Industrial, requesting that Xpress reverse engineer the pipettes and create a technical drawing displaying the pipette dimensions. This drawing, referred to as the “SLI drawing,” is as follows:

Notably, it is unclear why Scantibodies needed to have Xpress create the SLI drawing because Scantibodies was already in possession of Quidel’s technical drawing for the pipettes. Quidel’s drawing is as follows:

-2- Importantly, the Quidel drawing included the following volume requirement: “DISPENSE VOLUME: 120μl ± 10%, USING DEIONIZED WATER,” but the SLI drawing did not.

B. PURCHASE NEGOTIATIONS

In July 2020, Jorge Guerra, Scantibodies’ Purchasing Manager, e-mailed Luis Rodriguez, a Bekum representative, inquiring about potentially purchasing blow molding machines in order to produce pipettes for Quidel, and the SLI drawing was attached to this e-mail. Guerra testified that when responding to the initial inquiry, Rodriguez told him that Bekum was “familiar with the production of pipettes and that the machines are capable of doing it, stating that [Bekum] actually made extrusion molding machines for pipettes.” But Guerra explained that Rodriguez failed to mention that Bekum’s experience with pipette-molding machines was related to a single machine created in the 1990s.

C. THE PURCHASE

After further negotiations, Scantibodies agreed to purchase one H-121S machine and three 707D machines. The H-121S machine—a smaller machine that was previously used at Ferris State University—was purchased after Scantibodies inquired about any used or refurbished equipment that would expedite pipette production. In October 2020, Bekum sent Scantibodies an order confirmation for the H-121S machine, which included an interrelated pipette trimming station, totaling $406,151. Bekum also sent Scantibodies three separate order confirmations for the three separate 707D machines, together totaling $4,237,822.50. Scantibodies signed all four order

-3- confirmations and paid Bekum a down payment for each machine. Bekum agreed to deliver the H-121S machine by mid-December 2020, the first 707D machine by the end of August 2021, the second 707D machine by mid-October 2021, and the third 707D machine by mid-December 2021.

Notably, each order confirmation included an article tolerance table, but only the H-121S order confirmation referenced the SLI drawing. Each order confirmation also included identical terms and conditions of sale

D. PREPARATION OF THE H-121S MACHINE

In the beginning of November 2020, Bekum obtained the H-121S machine and began inspecting it for Scantibodies. Bekum worked with Compact Mould to create an eight-cavity mold for the machine—this mold was produced in accordance with the SLI drawing. Once the mold arrived, Bekum fine-tuned the machine settings and process. Joseph Slenk, a Bekum engineer, took responsibility for developing this process.

E. SCANTIBODIES’ FIRST ATTEMPT TO CANCEL THE CONTRACTS

In late November 2020, Scantibodies learned that Quidel was planning to purchase pipettes from another party. As a result, Scantibodies informed Bekum that it wanted to cancel its orders for the 707D machines and requested that Bekum supply any proposed cancellation costs. Bekum provided Scantibodies with three options, one of which included a potential 25% cancellation fee, but by mid-December 2020, Scantibodies informed Bekum that it intended to proceed with the orders as originally planned.

F. DELIVERY OF THE H-121S MACHINE

Before the scheduled virtual factory acceptance test (VFAT),1 Scantibodies e-mailed Bekum a list of “critical dimensions” for the pipettes. Notably, the pictured diagram attached to this e-mail was identical to the Quidel drawing, but it did not list any of the writing from the Quidel drawing, including the volume requirement. After fine-tuning the H-121S machine, and before the VFAT, Slenk sent Scantibodies sample pipettes created on the machine for inspection.

On December 14, 2020, Bekum timely tendered the H-121S machine for the parties’ scheduled VFAT, which occurred at Bekum’s facility. At the VFAT, Bekum’s technical team demonstrated the machine’s operation and pipette processing to Scantibodies’ representatives via video conference. During the VFAT, a Scantibodies representative told Slenk that the pipettes had an inconsistent internal diameter and dispensed inconsistent volumes of water; Slenk told the representative that he could solve the variations in dimensions by changing the machine settings. On December 15, 2020, Scantibodies signed the machine acceptance form, which indicated that the H-121S machine passed the VFAT. Slenk testified that after the VFAT, he made a “very common change” in the machine, which allowed the pipettes to “achieve the dimension

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Titan Insurance Company v. Hyten
491 Mich. 547 (Michigan Supreme Court, 2012)
Cooper v. Auto Club Ins. Ass'n
751 N.W.2d 443 (Michigan Supreme Court, 2008)
Van Tassel v. McDonald Corp.
407 N.W.2d 6 (Michigan Court of Appeals, 1987)
Papo v. Aglo Restaurants of San Jose, Inc
386 N.W.2d 177 (Michigan Court of Appeals, 1986)
Innovative Adult Foster Care, Inc v. Ragin
776 N.W.2d 398 (Michigan Court of Appeals, 2009)
Reed v. Reed
693 N.W.2d 825 (Michigan Court of Appeals, 2005)
Kelynack v. Yamaha Motor Corp.
394 N.W.2d 17 (Michigan Court of Appeals, 1986)
Computer Network, Inc. v. AM General Corp.
696 N.W.2d 49 (Michigan Court of Appeals, 2005)
Heritage Resources, Inc. v. Caterpillar Financial Services Corp.
774 N.W.2d 332 (Michigan Court of Appeals, 2009)
Zeeland Farm Services, Inc v. Jbl Enterprises, Inc
555 N.W.2d 733 (Michigan Court of Appeals, 1996)
Sun Valley Foods Co. v. Ward
596 N.W.2d 119 (Michigan Supreme Court, 1999)
Zaremba Equipment, Inc. v. Harco National Insurance
761 N.W.2d 151 (Michigan Court of Appeals, 2008)
Novak v. Nationwide Mutual Insurance
599 N.W.2d 546 (Michigan Court of Appeals, 1999)
Dobbelaere v. Auto-Owners Insurance
740 N.W.2d 503 (Michigan Court of Appeals, 2007)
Detroit City Council v. Mayor of Detroit
770 N.W.2d 117 (Michigan Court of Appeals, 2009)
Huron Tool and Engineering Co. v. Precision Consulting Services, Inc.
532 N.W.2d 541 (Michigan Court of Appeals, 1995)
Hayes Construction Co. v. Silverthorn
72 N.W.2d 190 (Michigan Supreme Court, 1955)
Village of Edmore v. Crystal Automation Systems Inc
911 N.W.2d 241 (Michigan Court of Appeals, 2017)
Michigan Education Ass'n v. Secretary of State
489 Mich. 194 (Michigan Supreme Court, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
Bekum America Corp v. Scantibodies Laboratory Inc, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bekum-america-corp-v-scantibodies-laboratory-inc-michctapp-2025.